Oberwil, Switzerland

Heinrich Rueger

This inventor holds 3 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Rueger. Retrieved from https://idiyas.com/inventor/heinrich-rueger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Heinrich Rueger: Innovator in Antihypertensive Compounds

Introduction

Heinrich Rueger is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compounds. With a total of 3 patents to his name, Rueger's work has the potential to impact the treatment of hypertension.

Latest Patents

Rueger's latest patents focus on antihypertensive 5-amino-4-hydroxyvaleryl derivatives. These compounds are designed to inhibit the blood pressure-increasing action of the enzyme renin. The innovative formula includes various substituents that enhance the efficacy of these compounds as anti-hypertensives.

Career Highlights

Heinrich Rueger has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has contributed to advancements in hypertension treatment, showcasing his expertise in medicinal chemistry.

Collaborations

Rueger has collaborated with notable colleagues such as Peter Buhlmayer and James L Stanton. These partnerships have fostered a collaborative environment that enhances innovation in their research endeavors.

Conclusion

Heinrich Rueger's contributions to the field of antihypertensive compounds highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…